Jorge Humberto Rodríguez-Quintero

Dr. Jorge Humberto Rodríguez-Quintero

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2021 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
JAJorge Luis Aguilar-Frasco
Jorge Luis Aguilar-Frasco
JRJorge Humberto Rodríguez-Quintero
Jorge Humberto Rodríguez-Quintero
PMPaulina Moctezuma-Velázquez
Paulina Moctezuma-Velázquez
JMJesús Morales-Maza
Jesús Morales-Maza
CMCarlos Moctezuma-Velázquez
Carlos Moctezuma-Velázquez
HMHeriberto Medina-Franco
Heriberto Medina-Franco

28 November 2018 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
JAJorge Aguilar-Frasco
Jorge Aguilar-Frasco
CRChristopher Ruben-Castillo
Christopher Ruben-Castillo
JRJorge Humberto Rodríguez-Quintero
Jorge Humberto Rodríguez-Quintero
HMHeriberto Medina-Franco
Heriberto Medina-Franco
Aggressive angiomyxoma (AA) is a rare mesenchymal tumour that sporadically arises in soft-tissues of perineum and pelvis. It was first described by Steeper and Rosay[1][1] in 1983 and approximately 300 cases of this neoplasm have been reported in literature since then. It usually presents in

23 January 2024 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
JRJorge Humberto Rodríguez-Quintero
Jorge Humberto Rodríguez-Quintero
MEMostafa M Elbahrawy
Mostafa M Elbahrawy
AMAnne Michelle Montal
Anne Michelle Montal
RJRajika Jindani
Rajika Jindani
MVMarc Vimolratana
Marc Vimolratana
NCNeel P Chudgar
Neel P Chudgar
OBJECTIVES: Recent randomized data support the perioperative benefits of minimally invasive surgery (MIS) for non-small-cell lung cancer (NSCLC). Its utility for cT4 tumours remains understudied. We, therefore, sought to analyse national trends and outcomes of minimally invasive resections for cT4 cancers. METHODS: Using the 2010–2019 National Cancer Database, we identified patients with cT4N0-1 NSCLC. Patients were stratified by surgical approach. Multivariable logistic analysis was used to identify factors associated with use of a minimally invasive approach. Groups were matched using propensity score analysis to evaluate perioperative and survival end points. RESULTS: The study identified 3715 patients, among whom 64.1% (n = 2381) underwent open resection and 35.9% (n = 1334) minimally invasive resection [robotic-assisted in 31.5% (n = 420); and video-assisted in 68.5% (n = 914)]. Increased MIS use was noted among patients with higher income [≥$40 227, odds ratio (OR) 1.24; 95% confidence interval (CI) 1.01–1.51] and those treated at academic hospitals (OR 1.25; 95% CI 1.07–1.45). Clinically node-positive patients (OR 0.68; 95% CI 0.55–0.83) and those who underwent neoadjuvant therapy (OR 0.78; 95% CI 0.65–0.93) were less likely to have minimally invasive resection. In matched groups, patients undergoing MIS had a shorter median length of stay (5 vs 6 days, P < 0.001) and no significant differences between 30-day readmissions or 30/90-day mortality. MIS did not compromise overall survival (log-rank P = 0.487). CONCLUSIONS: Nationally, the use of minimally invasive approaches for patients with cT4N0-1M0 NSCLC has increased substantially. In these patients, MIS is safe and does not compromise perioperative outcomes or survival.

1 October 2019 in Revista de Gastroenterología de México
Verified
Journal Article
Open access
JMJ. Morales-Maza
J. Morales-Maza
JRJorge Humberto Rodríguez-Quintero
Jorge Humberto Rodríguez-Quintero
OSO. Santes
O. Santes
AHA.C. Hernández-Villegas
A.C. Hernández-Villegas
UCU. Clemente-Gutiérrez
U. Clemente-Gutiérrez
MMM.A. Mercado
M.A. Mercado
Acute cholecystitis is one of the most frequent diseases faced by the general surgeon. In recent decades, different prognostic factors have been observed, and effective treatments described, to improve the results in patients with said pathology (lower morbidity and mortality, shorter hospital stay, and minimum conversion of laparoscopic to open procedures). In general, laparoscopic cholecystectomy is the standard treatment for acute cholecystitis, but it is not exempt from complications, especially in patients with numerous comorbidities or those that are critically ill. Percutaneous cholecystostomy emerged as a less invasive alternative for the treatment of acute cholecystitis in patients with organ failure or a prohibitive surgical risk. Even though it is an effective procedure, its usefulness and precise indications are subjects of debate. In addition, there is little evidence on cholecystostomy catheter management. We carried out a review of the literature covering the main aspects physicians involved in the management of acute cholecystitis should be familiar with.

26 July 2024 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
RJRajika Jindani
Rajika Jindani
JOJustin Olivera
Justin Olivera
JRJorge Humberto Rodríguez-Quintero
Jorge Humberto Rodríguez-Quintero
PFPatricia Friedmann
Patricia Friedmann
MVMarc Vimolratana
Marc Vimolratana
BSBrendon Stiles
Brendon Stiles

1 January 2019 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
EREmilio Sanchez-Garcia Ramos
Emilio Sanchez-Garcia Ramos
RCRubén Cortes
Rubén Cortes
ALAlexandra Rueda de Leon
Alexandra Rueda de Leon
ECEmmanuel Contreras-Jimenez
Emmanuel Contreras-Jimenez
JRJorge Humberto Rodríguez-Quintero
Jorge Humberto Rodríguez-Quintero
AAAlejandro Alfaro-Goldaracena
Alejandro Alfaro-Goldaracena
Introduction: Esophageal Schwannoma is a rare tumor that represents the least frequent mesenchymal tumor of the esophagus and represents a condition with only a few cases reported in the literature Presentation of a case: We report a 40-year-old female with a 5 years history of gastroesophageal reflux, repeated history of pharyngitis, odynophagia that culminated in progressive oropharyngeal dysphagia to solids. A barium esophagogram revealed a filling defect in the superior and middle thirds of the esophagus. Upper gastrointestinal endoscopy showed a smooth elevated lesion in the upper third of the esophagus, impossible to resect by this mean. An open left cervical approach revealed an 80 × 45 × 20 mm large tumor, which was resected. Discussion: In general, Schwanommas are rarely found in the gastrointestinal tract (GI), while the great majority occur in the stomach, esophagic is the least common GI form of presentation. Conclusion: The knowledge about a new case, impacts in obtaining more information about the clinical course and surgical treatment of this tumor. Highlights: